Evidence map›Paper›PMID 34208143›Full record

ArticleNutrients2021

Association between the

Rafael Molina-Luque, Natalia Ulloa, Manuel Romero-Saldaña, Martin Zilic, Andrea Gleisner, Fabián Lanuza, Guillermo Molina-Recio

Abstract read
In one paragraph

Article in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rafael Molina-LuqueGrupo Asociado de Investigación Estilos de Vida, Innovación y Salud, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14004 Córdoba, Spain.ORCID 0000-0002-5223-7400
Natalia UlloaCentro de Vida Saludable, Universidad de Concepción, Concepción 4070386, Chile.ORCID 0000-0002-0437-5016
Manuel Romero-SaldañaGrupo Asociado de Investigación Estilos de Vida, Innovación y Salud, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14004 Córdoba, Spain.ORCID 0000-0002-6146-4402
Martin ZilicFacultad de Medicina, Universidad de Concepción, Concepción 4070386, Chile.
Andrea GleisnerDepartamento de Pediatría, Facultad de Medicina, Universidad de Concepción, Concepción 4070386, Chile.
Fabián LanuzaEn Representación de el Consorcio ELHOC Chile (Epidemiology of Lifestyle and Health Outcomes in Chile), Concepción 4070386, Chile.ORCID 0000-0001-8545-9301
Guillermo Molina-RecioGrupo Asociado de Investigación Estilos de Vida, Innovación y Salud, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14004 Córdoba, Spain.ORCID 0000-0002-0005-4901

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe increasing prevalence of obesity in children has raised the incidence of Metabolic Syndrome (MetS) in this age group. Given the short- and long-term health impact of MetS, it is essential to prevent its onset by detecting its main triggers. Besides, genetic factors play an essential role in influencing which individuals within a population are most likely to develop obesity in response to a particular environment. In this regard, a common variation in the FTO gene is reproducibly associated with BMI and obesity from childhood and the genetic load has been linked to several cardiovascular risk factors, highlighting the FTO single nucleotide polymorphism (SNP) rs9939609. Therefore, this study aimed to establish the relationship between the FTO SNP rs9939609 and MetS.

methodsA cross-sectional study was carried out on 220 children from the Biobío region (Chile). MetS diagnosis was established through the modified Cook criteria, using prevalence ratios, COR curves, and linear regressions to determine its association with MetS and its components.

resultsThe prevalence of MetS was significantly increased among carriers of the risk allele (A): TT, 20.2%; TA, 25.4%; AA, 44.7% (

conclusionsThe FTO SNP rs9939609 was associated with a raised prevalence of MetS among A allele carriers, and was higher in the homozygous genotype (AA).

Indexed as

Polymorphism, Single NucleotideAlpha-Ketoglutarate-Dependent Dioxygenase FTOBody Mass IndexChildChileCross-Sectional StudiesFemaleGenetic Predisposition to DiseaseHumansMaleMetabolic SyndromeAlpha-Ketoglutarate-Dependent Dioxygenase FTOFTO protein, humanchildrenFTO genemetabolic syndrome

Identifiers

PMID34208143
PMCPMC8230726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.